▟ Vinebot intrinsic value, daily

← back

CB Chubb Limited

insurance · valued with opus medium conviction · deep-dived 2026-11-12

HOLD
Intrinsic value$325.66
Price (at call)$370.33
Margin of safety -12.1%
vs market (rating basis) +5.1%

Elite underwriter now priced slightly above normalized value; soft-market risk caps upside at 14% ROE.

The story

Chubb remains the best-in-class global P&C underwriter, with a diversified commercial, specialty, A&H and Asia life franchise and a conservatively reserved, high-quality balance sheet. Trailing ROE of 15.2% reflects peak-ish underwriting margins and elevated reinvestment yields, but commercial P&C pricing is softening and catastrophe losses are lumpy. Book value keeps compounding through retained earnings and buybacks, but the stock re-rated about 8% since our last take without a matching change in normalized fundamentals.

I kept every driver unchanged. The trailing 15.2% ROE is above our 14% through-the-cycle figure because the soft-market phase and normal catastrophe years still lie ahead, and higher investment income only partly offsets that. Book growth of 7% now, fading to 4.5%, fits earnings retention net of buybacks and dividends. A beta of 0.8 and a very low failure probability reflect the AA-rated balance sheet and conservative reserving.

Value drivers

Return on equity (normalized)14.0%
Book-value growth (Y1)7.0%
Terminal book growth4.5%
Beta0.80
Failure probability0.2%
Cost of equity8.6%

Valuation bridge

PV of excess returns23.33B
PV of terminal excess27.59B
Equity value124.43B
÷ shares → per share$325.66

Projected excess returns on equity

YrBook equityROEExcess returnPV
173.76B 14.0%3.98B 3.67B
278.92B 13.6%3.96B 3.36B
384.23B 13.2%3.91B 3.06B
489.65B 12.9%3.83B 2.75B
595.18B 12.5%3.70B 2.45B
6100.79B 12.1%3.54B 2.16B
7106.44B 11.7%3.34B 1.87B
8112.12B 11.4%3.09B 1.60B
9117.79B 11.0%2.80B 1.33B
10123.41B 10.6%2.47B 1.08B

Key risks

  • Commercial P&C pricing softening compresses combined ratios faster than expected
  • Large catastrophe or social-inflation reserve strengthening in US casualty lines
  • Falling rates erode reinvestment yields and net investment income

Catalysts

  • Sustained low-80s combined ratio plus rising net investment income pushing ROE above 15% through a soft market
  • Accretive international or Asia life acquisition deploying excess capital

History

DatePriceIntrinsicMoSRating
2026-11-12$370.33 $325.66 -12.1% HOLD
2026-10-12$341.20 $314.32 -7.9% BUY
2026-09-09$336.64 $329.46 -2.1% BUY
2026-08-07$354.03 $329.57 -6.9% BUY
2026-07-06$361.17 $339.92 -5.9% BUY
2026-06-23$332.11 $336.04 +1.2% BUY